RebeccaLynnMorooseMD

PubMed

• 17 citations
  Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapyendocrine therapy alone in patients with HR+/HER2- early breast cancer.
  Dennis J Slamon, Peter A Fasching, Sara Hurvitz, Stephen Chia, John Crown, Miguel Martín, Carlos H Barrios, Aditya Bardia, Seock-Ah Im, Denise A Yardley, Michael Untch...> ;Therapeutic Advances in Medical Oncology. 2023 Jan 1
• 5 citations
  Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment.
  Cen Guo, Yanke Yu, Jayeta Chakrabarti, Sarina A Piha-Paul, Rebecca Moroose, Anna Plotka, Haihong Shi, Chandrasekar Durairaj, Diane D Wang, Zev A Wainberg> ;British Journal of Clinical Pharmacology. 2022 Jul 1
• 3 citations
  Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood.
  Amanda Cox, Ana Martini, Heba Ghozlan, Rebecca Moroose, Xiang Zhu, Eunkyung Lee, Amr S Khaled, Louis Barr, Carlos Alemany, Na'im Fanaian, Elizabeth Griffith, Ryan Saus...> ;Plos One. 2022 Jan 1
• 81 citations
  Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial
  Kevin Kalinsky, Jennifer R. Diamond, Linda T. Vahdat, Sara M. Tolaney, Dejan Juric, Joyce O'Shaughnessy, RL Moroose, Ingrid A. Mayer, Vandana G. Abramson, David M. Gol...> ;Annals of Oncology. 2020 Dec 1
• 8 citations
  Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors.
  Justin Hoffman, Jayeta Chakrabarti, Anna Plotka, Adriana Milillo Naraine, David Kanamori, RL Moroose, Linh Nguyen, Diane Wang, Zev A. Wainberg> ;Anti-Cancer Drugs. 2019 Jun 1
• 437 citations
  Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
  Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat, Sara M. Tolaney, Steven J. Isakoff, Jennifer R. Diamond, Joyce O'Shaughnessy, Rebecca L. Moroose, Alessandro D. Santin...> ;The New England Journal of Medicine. 2019 Feb 20
• 14 citations
  Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy.
  Patrick J. Kelly, Zhe Ma, Said Baidas, Rebecca L. Moroose, N. Shah, Roi Dagan, Eleftherios P. Mamounas, Justin Rineer> ;International Journal of Breast Cancer. 2017 Sep 25
• 182 citations
  Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.
  Aditya Bardia, Ingrid A. Mayer, Jennifer R. Diamond, Rebecca L. Moroose, Steven J. Isakoff, Alexander Starodub, Nikita C. Shah, Joyce O'Shaughnessy, Kevin Kalinsky, Mi...> ;Journal of Clinical Oncology. 2017 Mar 14
• 93 citations
  Safety and Efficacy of Neratinib in Combination With Capecitabine in Patients With Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
  Cristina Saura, José A. García-Sáenz, Binghe Xu, Wael Harb, Rebecca L. Moroose, Timothy Pluard, Javier Cortes, Corinne Kiger, C. Germa, Kongming Wang, Miguel Martin, J...> ;Journal of Clinical Oncology. 2014 Nov 10
• 66 citations
  Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase ...
  Miguel Martin, Henri Roché, Tamás Pintér, John Crown, M. John Kennedy, Louise Provencher, Frank Priou, Wolfgang Eiermann, Encarna Adrover, István Láng, Manuel Ramos, J...> ;The Lancet. Oncology. 2011 Apr 1
• 8 citations
  A phase II trial of docetaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (TORI B01).
  Sara A. Hurvitz, Heather Allen, Rebecca L. Moroose, David Chan, Christopher T Hagenstad, Steven H. Applebaum, Giribala Patel, Eddie H. Hu, Nancy Ryba, Lii-Shin Lin, He...> ;Clinical Breast Cancer. 2010 Aug 1
• 101 citations
  Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery
  John L. Francis, George J Palmer, Rebecca Moroose, Alane Drexler> ;The Annals of Thoracic Surgery. 2003 Jan 1
• 62 citations
  Surreptitious Ingestion of a Long-Acting Vitamin K Antagonist/Rodenticide, Brodifacoum: Clinical and Metabolic Studies of Three Cases
  Jeffrey N. Weitzel, James A. Sadowski, Barbara C. Furie, Rebecca Moroose, Hugh Kim, Michael E. Mount, Michael J. Murphy, Bruce Furie> ;Blood. 1990 Dec 15
• 25 citations
  Gamma-glutamylcysteine synthetase deficiency and hemolytic anemia.
  Ernest Beutler, Rebecca Moroose, Lawrence Kramer, Terri Gelbart, Linda Forman> ;Blood. 1990 Jan 1
• von Willebrand factor and platelet function.
  Moroose, R., Hoyer, L. W.> ;Annu Rev Med. 1986
• In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
  Perry, A. S., Loftus, B., Moroose, R., Lynch, T. H., Hollywood, D., Watson, R. W., Woodson, K., Lawler, M.> ;Br J Cancer. 2007 May 21
• Join now to see all